Ignite Creation Date:
2024-05-05 @ 12:06 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00245427
Status:
COMPLETED
Last Update Posted:
2007-10-31
First Post:
2005-10-26
Brief Title:
Outcomes of Patients Not Responding to Antibiotics in the Community
Sponsor:
CPL Associates
Organization:
CPL Associates
Study Overview
Official Title:
Outcomes of Patients Not Responding to Outpatient Macrolide or b-Lactam Therapy for the Treatment of Community Acquired Pneumonia Expansion to Include Acute Exacerbations of Chronic Bronchitis and Acute Sinusitis
Status:
COMPLETED
Status Verified Date:
2007-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A study to report the outcomes of patients who fail to respond to beta-lactam and macrolide antibiotics in the community
Detailed Description:
To document and describe the clinical microbiological and pharmacoeconomic outcomes of two hundred patients who failed to respond to outpatient macrolide or beta-lactam therapy Evaluable patients must have a positive culture obtained after they failed their initial macrolide or beta-lactam The isolated pathogen must have a known MIC to the antibiotic class they failed to respond to ie macrolide or b-lactam The isolate must be available to be sent to the central laboratory for MIC testing
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None